Zobrazeno 1 - 10
of 382
pro vyhledávání: '"Soo, R. A."'
Autor:
Soo, R., Mery, L., Bardot, A., Kanesvaran, R., Keong, T.C., Pongnikorn, D., Prasongsook, N., Hutajulu, S.H., Irawan, C., Manan, A. Ab, Thiagarajan, M., Sripan, P., Peters, S., Storm, H., Bray, F., Stahel, R.
Publikováno v:
In ESMO Open October 2022 7(5)
Autor:
Addeo, A., Albiges, L., Ascierto, P.A., Banerjee, S., Barlesi, F., Caldas, C., Cardoso, F., Cervantes, A., Chaberny, I.F., Cherny, N.I., Choueiri, T.K., Chua, M.L.K., Criscitiello, C., Curigliano, G., de Azambuja, E., De Ruysscher, D., de Vries, E., Dent, R., Douillard, J.Y., D’Ugo, D., Dziadziuszko, R., Faivre-Finn, C., Felip, E., Garassino, M., Garrido, P., Girard, N., Glynne-Jones, R., Golfinopoulos, V., Haanen, J., Hamilton, E., Jänne, P.A., Jordan, K., Kanesvaran, R., Kim, S.B., Liebert, U.G., Lordick, F., Machiels, J.P., Michielin, O., Mok, T.S.K., Morgan, G., Obermannova, R., Park, K., Passaro, A., Pentheroudakis, G., Peters, S., Reck, M., Salazar Soler, R., Scotté, F., Senan, S., Sessa, C., Smyth, E., Soo, R., Soria, J.C., Spicer, J., Strasser, F., Tabernero, J., Tan, D.S.W., Trapani, D., Van Cutsem, E., van Halteren, H., van Schil, P.E., Veronesi, G., Yang, J., Garassino, M.C.
Publikováno v:
In Annals of Oncology October 2020 31(10):1320-1335
Autor:
Planchard, D., Reinmuth, N., Orlov, S., Fischer, J.R., Sugawara, S., Mandziuk, S., Marquez-Medina, D., Novello, S., Takeda, Y., Soo, R., Park, K., McCleod, M., Geater, S.L., Powell, M., May, R., Scheuring, U., Stockman, P., Kowalski, D.
Publikováno v:
In Annals of Oncology May 2020 31(5):609-618
Autor:
Sands, Bryan, Burnaevskiy, Nikolay, Yun, Soo R., Crane, Matthew M., Kaeberlein, Matt, Mendenhall, Alexander
Publikováno v:
In Translational Medicine of Aging January 2018 2:1-10
Autor:
Bryan Sands, Nikolay Burnaevskiy, Soo R. Yun, Matthew M. Crane, Matt Kaeberlein, Alexander Mendenhall
Publikováno v:
Translational Medicine of Aging, Vol 2, Iss , Pp 1-10 (2018)
One way scientists can observe and quantify processes in living cells is to engineer the genomes of animals to express multiple fluorescent proteins and then quantify those signals by various imaging techniques. To allow our laboratories to confident
Externí odkaz:
https://doaj.org/article/069145c92079481f9a1b8a182e305448
Autor:
Dafni, U., Soo, R. A., Peters, S., Tsourti, Z., Zygoura, P., Vervita, K., Han, J-Y, De Castro, J., Coate, L., Fruh, M., Hashemi, S. M. S., Nadal, E., Carcereny, E., Sala, M. A., Bernabe, R., Provencio, M., Cuffe, S., Roschitzki-Voser, H., Ruepp, B., Rosell, R., Stahel, R. A.
Background: The ETOP 10-16 BOOSTER trial failed to demonstrate a progression-free survival (PFS) benefit for adding bevacizumab to osimertinib in second line. An exploratory subgroup analysis, however, suggested a PFS benefit of the combination in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2636::801bc88be8f25f3fa5e318e970392eab
https://hdl.handle.net/10668/22216
https://hdl.handle.net/10668/22216
Autor:
Smeltzer, M., Connolly, C., Lantuejoul, S., Soo, R., Kerpel-Fronius, A., Mohan, A., Woodard, G., Basu Roy, U., Chau, M., Brunson, K., Santos, R., Wynes, M., King, J.C., Young, A., Yatabe, Y., Kelly, K.
Publikováno v:
Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS12-S13, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ho, C., Soon, Y.Y., Nichol, A., Robledo, K., Sahgal, A., Pinkham, M., Melosky, B., Huang, Y., Parmar, A., Solomon, B., Tham, I.W.K., Sacher, A., Tey, J.C.S., Menjak, I., Leong, C.N., Shultz, D., Koh, W.Y., Doherty, M., Ang, Y., Low, J., Yong, C., Lim, M.C., Tan, A.P., Lee, C.K., Soo, R., Lefresne, S., Hegi-Johnson, F.
Publikováno v:
In Journal of Thoracic Oncology October 2024 19(10) Supplement:S28-S29
Autor:
Dafni, U, Soo, R A, Peters, S, Tsourti, Z, Zygoura, P, Vervita, K, Han, J-Y, De Castro, J, Coate, L, Früh, M, Hashemi, S M S, Nadal, E, Carcereny, E, Sala, M A, Bernabé, R, Provencio, M, Cuffe, S, Roschitzki-Voser, H, Ruepp, B, Rosell, R, Stahel, R A
Publikováno v:
Dafni, U; Soo, R A; Peters, S; Tsourti, Z; Zygoura, P; Vervita, K; Han, J-Y; De Castro, J; Coate, L; Früh, M; Hashemi, S M S; Nadal, E; Carcereny, E; Sala, M A; Bernabé, R; Provencio, M; Cuffe, S; Roschitzki-Voser, H; Ruepp, B; Rosell, R; ... (2022). Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysis. ESMO open, 7(3), p. 100507. Elsevier 10.1016/j.esmoop.2022.100507
Dafni, U, Soo, R A, Peters, S, Tsourti, Z, Zygoura, P, Vervita, K, Han, J Y, de Castro, J, Coate, L, Früh, M, Hashemi, S M S, Nadal, E, Carcereny, E, Sala, M A, Bernabé, R, Provencio, M, Cuffe, S, Roschitzki-Voser, H, Ruepp, B, Rosell, R & Stahel, R A 2022, ' Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC—a systematic review and meta-analysis ', ESMO OPEN, vol. 7, no. 3, 100507 . https://doi.org/10.1016/j.esmoop.2022.100507
ESMO OPEN, 7(3):100507. BMJ Publishing Group
Dafni, U, Soo, R A, Peters, S, Tsourti, Z, Zygoura, P, Vervita, K, Han, J Y, de Castro, J, Coate, L, Früh, M, Hashemi, S M S, Nadal, E, Carcereny, E, Sala, M A, Bernabé, R, Provencio, M, Cuffe, S, Roschitzki-Voser, H, Ruepp, B, Rosell, R & Stahel, R A 2022, ' Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC—a systematic review and meta-analysis ', ESMO OPEN, vol. 7, no. 3, 100507 . https://doi.org/10.1016/j.esmoop.2022.100507
ESMO OPEN, 7(3):100507. BMJ Publishing Group
BACKGROUND The ETOP 10-16 BOOSTER trial failed to demonstrate a progression-free survival (PFS) benefit for adding bevacizumab to osimertinib in second line. An exploratory subgroup analysis, however, suggested a PFS benefit of the combination in pat